You are here:

NICE
NICE Guidance
Conditions and diseases
Cancer
Prostate cancer

Degarelix for treating advanced hormone-dependent prostate cancer

Technology appraisal guidance
Reference number: TA404
Published: 24 August 2016

Guidance
Tools and resources
Information for the public
Evidence
History

Final scrutiny letter

Final scrutiny letter

Final scrutiny letter
25 June 2014
(19.57 Kb 5 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 25 June 2014